Cargando…
Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis
Galectin-1 (Gal1) plays a regulatory role in the immune system. We have recently validated that Gal1 serum (sGal1) levels are increased in rheumatoid arthritis (RA) patients compared to healthy donors (HDs); however, there is no information on Gal1 in spondyloarthritis (SpA). Objective: To compare G...
Autores principales: | Triguero-Martínez, Ana, Roy-Vallejo, Emilia, Tomero, Eva Gloria, Montes, Nuria, de la Fuente, Hortensia, Ortiz, Ana María, Castañeda, Santos, Lamana, Amalia, González-Álvaro, Isidoro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658544/ https://www.ncbi.nlm.nih.gov/pubmed/36362537 http://dx.doi.org/10.3390/jcm11216313 |
Ejemplares similares
-
Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2020) -
Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin-1 Serum Levels in Patients with Early Arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022) -
Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity
por: Seoane, Iria V., et al.
Publicado: (2015) -
Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity
por: Lamana, Amalia, et al.
Publicado: (2020) -
REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients
por: González-Álvaro, Isidoro, et al.
Publicado: (2017)